00

Days

00

Hours

00

Minutes

00

Seconds

KEY EVENTS

Fellows Hands-On Lab

Thursday, July 16

6:00AM – 7:00PM

Fountainebleau Miami Beach
4441 Collins Avenue

Reveal-the-Loop: In-Booth Live Demonstration of the Evoke® System

Friday, July 17

10:20AM-10:40AM

Exhibition Hall • Booth 7A

Johnathan Goree, MD

Johnathan Goree, MD

Dylan Hays

Friday, July 17

7:30PM – 9:30PM

Nobu Miami Beach

Objective by Design: Disrupting Pain With the Evoke® System

Saturday, July 18

12:00PM – 1:00PM

Flicker 1-3

Saturday, July 18

7:30PM – 9:00PM

Ocean Social​
Miami Beach

Join us for an evening exploring how Evoke™
Therapy is disrupting pain by removing guesswork to move SCS forward.

Friday, July 17

7:30PM – 9:30PM

Nobu Miami Beach
4525 Collins Avenue

FACULTY

Ajay Antony, MD

Ajay Antony, MD

Brian Bruel, MD

Patrick Buchanan, MD

Lindsay Carter, NP

Eric Cornidez, MD

Eric Cornidez, MD

Dax Duncan, NP

Christopher Gilmore, MD

Johnathan Goree, MD

Johnathan Goree, MD

Leonardo Kapural, MD

Hemant Kalia, MD

Nasir Khatri, MD

Morad Nasseri, MD

Gabriel Pagani, MD

Erika Petersen, MD

Erika Petersen, MD

Jason Pope, MD

Jason Pope, MD

Jonathan Silverman, MD

Lawson Smith, MD

Lawson Smith, MD

Jordan Tate, MD

Drew Trainor, DO

Drew Trainor, DO

Derron Wilson, MD

Join us for a reception to learn how the Evoke® System and the next wave of neuromodulation is moving SCS forward.

Friday, July 18

7:30PM – 9:00PM

Ocean Social
Miami Beach

FACULTY

Hassan Aboumerhi, MD

Brian Bruel, MD

Patrick Buchanan, MD

Eric Cornidez, MD

Eric Cornidez, MD

Michael Dorsi, MD

Johnathan Goree, MD

Johnathan Goree, MD

Corey Hunter, MD

Corey Hunter, MD

Usman Latif, MD

Sean Li, MD

Morad Nasseri, MD

Erika Petersen, MD

Erika Petersen, MD

Jason Pope, MD

Jason Pope, MD

Dustin Reynolds, MD

Anuj Shah, MD

Please contact your Saluda Representative for additional details

Disrupting pain by removing guesswork.

Listen to the spinal cord not the representative

]The dose is anchored to each patient’s individual physiology – unlike others that are set subjectively by the programmer.

Therapy is individually calibrated from the start

Objectively scans and analyzes each patient’s unique spinal cord to identify therapeutic settings from day one of the trial phase.

Automatically adjusts to maintain consistent pain relief​

Continual adjustments address both over AND under dosing for sustainable, predictable pain relief.

Visit us at booth #7A

Interact with Saluda experts and discover more about the Evoke® System, now elevated by EVA Sensing Technology, and learn more about our life-changing technology.

Networking Lounge

Barista Zone

Saluda Experts

Podium Presentations

Neural Panel Study: Interim Analysis of a Multicenter Evaluation of a Next-Generation, Automated Programming Platform with Advanced Sensing Technology

Friday, July 17 ​

9:25-9:35AM

Fontaine Ballroom

Kasra Amirdelfan, MD

Real-World SCS Utilization and Explant Patterns in 1,000 Patients From a Multicenter Consecutive Case Series

Sunday, July 19

8:10-8:25AM

Fontaine Ballroom

Jason Pope, MD

Jason Pope, MD

Sessions of Interest

From Innovation to Impact in Pain Management: How Executives Align Intelligent Technology with Real World Care

Friday, July 17

1:30 – 1:50PM

Fontaine Ballroom

Does Evidence Actually Matter in SCS Selection?

Saturday, July 18

8:25 – 8:40AM

Fontaine Ballroom

SELECTED ABSTRACTS

Physiologic Closed Loop Controlled Spinal Cord Stimulation Can Rescue Historically Failed or Presently Failing Fixed-Output Spinal Cord Stimulation: A Case Series

Real-World SCS Utilization and Explant Patterns in 1,000 Patients From a Multicenter Consecutive Case Series

Use of Objective Metrics in Describing Efficacy of Spinal Cord Stimulation in Patients with Wearable Activity Trackers

Real-World Outcomes using Evoke® System with EVA Sensing Technology in Chronic Pain Management: Insights from the ULTRA Study

ECAP Dose-Controlled Closed-Loop Spinal Cord Stimulation in Complex Regional Pain Syndrome: A Subgroup Analysis of the ECAP Study

Clinical Outcomes of ECAP Dose-Controlled Closed-Loop Spinal Cord Stimulation in Chronic Non-Surgical Refractory Back Pain: Subgroup Analysis from Two Prospective Multicenter Trials

ECAP Dose-Controlled Closed-Loop Spinal Cord Stimulation in Painful Diabetic Neuropathy: A Subgroup Analysis of the ECAP Study

Neural Panel Study: Interim Analysis of a Multicenter Evaluation of a Next-Generation, Automated Programming Platform with Advanced Sensing Technology

Twelve-month Clinical Outcomes of ECAP Dose-Controlled Closed-Loop Spinal Cord Stimulation in Same Day Objective Trial Responders

Outcomes  in Real-World Practice Using a Next-Generation Automated Programming Platform Enabled by Advanced Sensing Technology